A settlement has reportedly been reached among litigants in multi district litigation proceedings involving the bankrupt New England Compounding Center (NECC) and its insurers and creditors, including those who allegedly contracted fungal meningitis linked to the compounding pharmacy’s tainted injectable steroid products. According to the plaintiffs’ steering committee, under the tentative agreement, which requires additional negotiation as well as court approval, a compensation fund potentially exceeding $100 million would be created for distribution to “victims and their families as compensation for the deaths, injuries and suffering they endured as a result of this tragic meningitis outbreak.” Plaintiffs’ counsel also noted that litigation would continue separately against clinics, doctors, hospitals, and NECC vendors allegedly at fault. The next court hearing in the matter is scheduled for January 10, 2014. See Business Wire, December 23, 2013; Reuters, December 24, 2013.